John Bennetts

John is a director, founder and owner of a range of businesses across a variety of industries including biotechnology, financial services and manufacturing.

He is a director and member of the Audit Committee of ASX listed McMillan Shakespeare and was a founder and director of Australian biotechnology company Cellestis Ltd, which has led the world in improving the diagnosis and treatment for tuberculosis.

Prior to moving into business John practiced as a commercial lawyer and has degrees in Law and Economics.